Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome
The Efficacy of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy in Patients With Bladder Pain Syndrome
Sponsor: Samsung Medical Center
Listed as NCT01895153, this observational or N/A phase trial focuses on Bladder Pain Syndrome and Hydrodistension and remains completed. Sponsored by Samsung Medical Center, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2020 — Jan 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2020 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: PHASE4 → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status PHASE4
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .